Are you looking for a new podcast about stuff related to money?

Well, today's your lucky day.

I'm Matt Levine.

And I'm Katie Greifeld.

And we are the hosts of Money Stuff, The Podcast.

Every Friday, we dive into the top stories about Wall Street, finance, and other stuff.

We have fun. We get weird, and we want you to join us. You can listen to

Many Stuff the Podcasts on Apple Podcasts, Spotify, or wherever you get your podcasts.

Welcome to Prognosis. I'm Laura Carlson. It's day 93 since coronavirus was declared a global pandemic.

Our main story? We're still learning about the effects that long-term isolation is having on young children.

Experts in many places still don't know whether school will resume in its normal form this fall,

which could leave children and their parents trying to navigate a healthy quarantine lifestyle

for months longer.

But first, here's what happened today.

Johnson & Johnson is accelerating trials of its COVID-19 vaccine. The company's chief

scientific officer says it's in a race against time, because we could be

facing a severe second wave of the virus. This week, the pharma giant said it would start

human trials in the second half of July, about two months earlier than expected. Final stage

tests could begin in September.

J&J's vaccine is one of more than 130 in development against the novel coronavirus,

according to the World Health Organization. The global economy is recovering from the pandemic

more slowly than experts expected.

...